首页>
外国专利>
COMBINED AGENT FOR CELL THERAPY OF CORNEAL ENDOTHELIAL CELL
COMBINED AGENT FOR CELL THERAPY OF CORNEAL ENDOTHELIAL CELL
展开▼
机译:联合治疗角膜上皮细胞的细胞治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides an agent for treating or preventing a disease, a disorder or a condition of a corneal endothelium, said agent comprising a corneal endothelial cell and a myosin II-specific inhibitor. More specifically, the myosin II-specific inhibitor is blebbistatin. The disease, the disorder or the condition is typically a disorder associated with Fuchs endothelial corneal dystrophy or corneal endothelial dysfunction (bullous keratopathy). Also provided is a method for treating or preventing a corneal endothelial disease, said method comprising a step of administering an effective amount of a myosin II-specific inhibitor together with a corneal endothelial cell to a subject.
展开▼